Drug recall · July 24, 2013
Estarylla recall
Why: Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets per carton. Rx only, Manufactured by Laboratorios Leon Farma S.A. Spain for Sandoz Inc. Princeton, NJ 08540, NDC 0781-4058-15
- Lots / codes
Lot: LF01213A, Exp. 02/14
- Quantity
- 10,848 cartons
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Distributed to one consignee in Indiana. No foreign, government, VA, or military consignees.
- Initiated
- June 21, 2013 · Voluntary: Firm initiated
- Classified
- July 17, 2013
- Reported
- July 24, 2013
- Ended
- January 29, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.